ElAbd H, Pesesky M, Innocenti G, Chung BK, Mahdy AKH, Kriukova V, Kulsvehagen L, Strobbe D, Stühler C, Mayr G, May DH, Prinzensteiner M, Steiert TA, Tran F, Hadjihannas MV, Günther R, Rosati E, Mucha S, Lieb W, Ziemann M, Dempfle A, Braun F, Folseraas T, Hov JR, Melum E et al. (2025)
T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis
Nat Med (in press)
DOI 10.1038/s41591-025-03692-w, PubMed 40500415

Zhu C, Boucheron N, Al-Rubaye O, Chung BK, Thorbjørnsen LW, Köcher T, Schuster M, Claudel T, Halilbasic E, Kunczer V, Muscate F, Cavanagh LL, Waltenberger D, Lercher A, Ohradanova-Repic A, Schatzlmaier P, Stojakovic T, Scharnagl H, Bergthaler A, Stockinger H, Huber S, Bock C, Kenner L, Karlsen TH, Ellmeier W et al. (2025)
24-Nor-ursodeoxycholic acid improves intestinal inflammation by targeting T_H17 pathogenicity and transdifferentiation
Gut, 74 (7), 1079-1093
DOI 10.1136/gutjnl-2024-333297, PubMed 40032499

Ellmeier W, Meijer M, Madrignani M, Simulescu L, Karlsen TH, Macintyre E, members of the BioMed Alliance Health Research Committee (2025)
Shaping the future of European health research: policy recommendations of the Biomedical Alliance in Europe for Framework Programme 10 and beyond
FEBS Lett (in press)
DOI 10.1002/1873-3468.70079, PubMed 40421770